Home NDC 61168-101 KYBELLA
Product NDC 61168-101
11-digit product format 611680101
Labeler code 61168
Product ID 61168-101_c67c4873-6322-42dc-8a2b-da3a7012a435
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Deoxycholic Acid
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Kythera Biopharmaceuticals Inc.
Application NDA206333
Marketing category NDA
Marketing start 2015-06-08
Substance DEOXYCHOLIC ACID
Active strength 20 mg/2mL
Pharmacologic classes Cytolytic Agent [EPC], Decreased Cell Membrane Integrity [PE]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N206333-001 KYBELLA DEOXYCHOLIC ACID 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N206333-001 AP
Orange Book patents# Current patent rows page 1 of 1 · 14 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N206333-001 7622130 2027-12-10 U-1690 2015-05-07 N206333-001 7754230 2027-12-10 U-1690 2015-05-07 N206333-001 8461140 2028-02-21 Drug product 2015-05-07 N206333-001 8546367 2028-02-21 U-1690 Drug product 2015-05-27 N206333-001 8883770 2028-02-21 Drug product 2015-05-27 N206333-001 9522155 2028-02-21 U-1940 Drug product 2017-01-19 N206333-001 9636349 2028-02-21 U-1940 2017-08-29 N206333-001 9949986 2028-02-21 U-1940 2018-05-24 N206333-001 8242294 2028-05-16 Drug substance 2015-05-07 N206333-001 10500214 2030-03-02 Drug product 2020-01-22 N206333-001 8101593 2030-03-02 Drug product 2015-05-07 N206333-001 8367649 2030-03-02 Drug product 2015-05-07 N206333-001 8653058 2030-03-02 Drug product 2015-05-07 N206333-001 12161653 2032-02-17 U-1940 2025-01-10
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2015-04-29 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2015-04-29 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2015-04-29 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2015-04-29 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2015-04-29 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2015-04-29 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2015-04-29 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N206333-001 KYBELLA 20MG/2ML (10MG/ML) SOLUTION / SUBCUTANEOUS AP RLD, RS 2015-04-29 e64feba35796…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 16 · 627 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N206333-001 7622130 2027-12-10 U-1690 2015-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 7754230 2027-12-10 U-1690 2015-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 8461140 2028-02-21 Drug product 2015-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 8546367 2028-02-21 U-1690 Drug product 2015-05-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 8883770 2028-02-21 Drug product 2015-05-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 9522155 2028-02-21 U-1940 Drug product 2017-01-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 9636349 2028-02-21 U-1940 2017-08-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 9949986 2028-02-21 U-1940 2018-05-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 8242294 2028-05-16 Drug substance 2015-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 10500214 2030-03-02 Drug product 2020-01-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 8101593 2030-03-02 Drug product 2015-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 8367649 2030-03-02 Drug product 2015-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 8653058 2030-03-02 Drug product 2015-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206333-001 12161653 2032-02-17 U-1940 2025-01-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N206333-001 7622130 2027-12-10 U-1690 2015-05-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 7754230 2027-12-10 U-1690 2015-05-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 8461140 2028-02-21 Drug product 2015-05-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 8546367 2028-02-21 U-1690 Drug product 2015-05-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 8883770 2028-02-21 Drug product 2015-05-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 9522155 2028-02-21 U-1940 Drug product 2017-01-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 9636349 2028-02-21 U-1940 2017-08-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 9949986 2028-02-21 U-1940 2018-05-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 8242294 2028-05-16 Drug substance 2015-05-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 10500214 2030-03-02 Drug product 2020-01-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 8101593 2030-03-02 Drug product 2015-05-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 8367649 2030-03-02 Drug product 2015-05-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 8653058 2030-03-02 Drug product 2015-05-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206333-001 12161653 2032-02-17 U-1940 2025-01-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 8846066 2025-02-08 U-1690 2015-05-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 8298556 2025-08-03 U-1690 2015-05-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 7622130 2027-12-10 U-1690 2015-05-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 7754230 2027-12-10 U-1690 2015-05-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 8461140 2028-02-21 Drug product 2015-05-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 8546367 2028-02-21 U-1690 Drug product 2015-05-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 8883770 2028-02-21 Drug product 2015-05-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 9522155 2028-02-21 U-1940 Drug product 2017-01-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 9636349 2028-02-21 U-1940 2017-08-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 9949986 2028-02-21 U-1940 2018-05-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 8242294 2028-05-16 Drug substance 2015-05-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206333-001 10500214 2030-03-02 Drug product 2020-01-22 31067a03dcf5…
Additional Listing Data#
Finished product Yes
Brand name base KYBELLA
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DEOXYCHOLIC ACID 20 mg/2mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 005990WHZZ Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1649975 Internal RxNorm lookup 1649980 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 61168-101-01 KYBELLA 2 mL in 1 VIAL, GLASS INJECTION, SOLUTION 2 25 61168-101-03 KYBELLA 2 in 1 CARTON INJECTION, SOLUTION 2 25 61168-101-03 KYBELLA 2 mL in 1 VIAL, GLASS INJECTION, SOLUTION 2 25 61168-101-04 KYBELLA 4 in 1 CARTON INJECTION, SOLUTION 4 25 61168-101-91 KYBELLA 2 mL in 1 VIAL, GLASS INJECTION, SOLUTION 2 25 61168-101-94 KYBELLA 4 in 1 CARTON INJECTION, SOLUTION 4 25
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Deoxycholic Acid ACTIVE INGREDIENT 005990WHZZ KYBELLA (DEOXYCHOLIC ACID) INJECTION, SOLUTION [KYTHERA BIOPHARMACEUTICALS INC.] 3 Deoxycholic Acid ACTIVE MOIETY 005990WHZZ KYBELLA (DEOXYCHOLIC ACID) INJECTION, SOLUTION [KYTHERA BIOPHARMACEUTICALS INC.] 3 Benzyl Alcohol INACTIVE INGREDIENT LKG8494WBH KYBELLA (DEOXYCHOLIC ACID) INJECTION, SOLUTION [KYTHERA BIOPHARMACEUTICALS INC.] 3 Hydrochloric Acid INACTIVE INGREDIENT QTT17582CB KYBELLA (DEOXYCHOLIC ACID) INJECTION, SOLUTION [KYTHERA BIOPHARMACEUTICALS INC.] 3 Sodium Chloride INACTIVE INGREDIENT 451W47IQ8X KYBELLA (DEOXYCHOLIC ACID) INJECTION, SOLUTION [KYTHERA BIOPHARMACEUTICALS INC.] 3 Sodium Hydroxide INACTIVE INGREDIENT 55X04QC32I KYBELLA (DEOXYCHOLIC ACID) INJECTION, SOLUTION [KYTHERA BIOPHARMACEUTICALS INC.] 3 Sodium Phosphate, Dibasic INACTIVE INGREDIENT GR686LBA74 KYBELLA (DEOXYCHOLIC ACID) INJECTION, SOLUTION [KYTHERA BIOPHARMACEUTICALS INC.] 3 Water INACTIVE INGREDIENT 059QF0KO0R KYBELLA (DEOXYCHOLIC ACID) INJECTION, SOLUTION [KYTHERA BIOPHARMACEUTICALS INC.] 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61168-101 KYBELLA (DEOXYCHOLIC ACID) INJECTION, SOLUTION [KYTHERA BIOPHARMACEUTICALS INC.] 24 Current NDC, Legacy NDC, 6 package rows 20250321_fe431ed4-ea6f-4e99-b4bc-ec25ae7b8553.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join KYBELLA DEOXYCHOLIC ACID Kythera Biopharmaceuticals Inc. fe431ed4-ea6f-4e99-b4bc-ec25ae7b8553 2024-10-30 Warnings, Adverse reactions Exact identifier application applno (NDA): 206333 application number: NDA206333 ndc (product): 61168-101
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 61168-101-01 61168010101 2 mL in 1 VIAL, GLASS 2 ml Historical 61168-101-03 61168010103 2 VIAL, GLASS in 1 CARTON (61168-101-03) / 2 mL in 1 VIAL, GLASS 2018-08-01 0000-00-00 Yes No Current 61168-101-04 61168010104 4 VIAL, GLASS in 1 CARTON (61168-101-04) / 2 mL in 1 VIAL, GLASS (61168-101-01) 2015-06-08 0000-00-00 No No Current 61168-101-91 61168010191 2 mL in 1 VIAL, GLASS 2 ml Historical 61168-101-94 61168010194 4 VIAL, GLASS in 1 CARTON (61168-101-94) > 2 mL in 1 VIAL, GLASS (61168-101-91) 2015-06-08 2022-01-30 No No Current